Cencora COR 深 沪
等待开盘 09-04 09:30:00 美东时间
337.22
+0.860
+0.26%
华盛通- 最 高338.71
- 今 开337.90
- 成交量 108.53万股
- 最 低 334.87
- 昨 收 336.36
- 总市值 643.51亿
- 52周最高 375.74
- 市盈率 静 42.36
- 换手率 0.57%
- 52周最低 243.62
- 委 比 11.11%
- 总股本 1.91亿
- 历史最高 375.74
- 量 比 0.90
- 振 幅 1.14%
- 历史最低 -9.225
- 每 手 1
- 风险率 29.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basis producing an average annual return of 19.83%. Currently, Cencora has a market capitalization of $59.16 billion. Buying $1000 In COR: If an investor had bought $1000 of COR stock 10 years ago, it wou...
08-14 04:45
Cencora dips on loss of some Walgreens business
Cencora (COR) shares fell in afternoon trading on Wednesday after the medical distributor disclosed that some of its business operations that previously served the pharmacy chain Walgreens are moving ...
08-13 01:20
Cencora Reaffirms 2026 EPS Outlook Amid Walgreens Shift
Cencora ( ($COR) ) just unveiled an announcement. Beginning July 1, 2026, certa...
08-13 00:57
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
U.S. SEC exempts certain data center bonds from asset-backed securities rules
The Securities and Exchange Commission has exempted certain data center bonds from key securitization rules, making it easier for data center operators to raise capital via the sale of asset-backed se...
08-11 01:55
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
UBS Maintains Buy on Cencora, Raises Price Target to $430
UBS analyst Kevin Caliendo maintains Cencora (NYSE:COR) with a Buy and raises the price target from $412 to $430.
08-07 03:05
财报速睇 | Cencora 2026财年Q2营收847.55亿美元，同比增长5.1%；归母净利润7.64亿美元，同比增长11.2%
华盛资讯8月6日讯，Cencora公布2026财年Q2业绩，公司Q2营收847.55亿美元，同比增长5.1%，归母净利润7.64亿美元，同比增长11.2%。
08-06 03:32
Cencora shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance with its midpoint above estimates.
Cencora shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance with its midpoint above estimates.
08-06 00:25
